Form 4: Roivant CFO Sells Shares for Tax Obligations

Roivant Sciences CFO Richard Pulik disposed of 1,235 common shares at $20.27 each to cover tax withholding related to RSU vesting.

Summary

• Richard Pulik, Chief Financial Officer (CFO) of Roivant Sciences Ltd. (ROIV), reported a transaction involving the company's common shares.
• On November 20, 2025, Pulik disposed of 1,235 common shares.
• The disposition occurred at a price of $20.27 per share.
• This transaction represents a "net settlement" by Roivant Sciences to satisfy applicable tax withholding obligations in connection with the vesting and settlement of previously granted Restricted Stock Units (RSUs).
• Following this reported transaction, Richard Pulik directly beneficially owns 388,273 common shares.

Sentiment

Score: 5

Explanation: This is a routine, non-discretionary transaction for tax withholding purposes related to RSU vesting. It does not reflect a discretionary sale or purchase by the insider and therefore carries a neutral sentiment regarding the company's prospects or the insider's confidence.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This is a standard insider transaction related to equity compensation and tax obligations, common across all industries for executives receiving Restricted Stock Units (RSUs). It does not reflect specific industry trends or competitive dynamics within the biotechnology and pharmaceutical sector where Roivant Sciences operates.

Comparison to Industry Standards

• The "net settlement" method for covering tax withholding on RSU vesting is a common and standard practice in corporate equity compensation plans across various industries.
• This method allows employees to satisfy tax obligations without needing to use personal funds or sell additional shares on the open market, which is a widely accepted approach for managing executive compensation.
• No specific comparable companies, projects, or results are relevant for this routine administrative transaction.

Stakeholder Impact

• Shareholders: Minimal impact. This is a small, routine disposition for tax purposes and does not signal a change in the company's fundamentals or management's long-term view.
• Employees: No direct impact beyond the reporting person.
• Customers/Suppliers/Creditors: No direct impact.

Key Dates

Keywords

Roivant Sciences, ROIV, Richard Pulik, CFO, Form 4, Insider Transaction, Share Sale, RSU, Restricted Stock Units, Tax Withholding, Equity Compensation